Showing results (511-520 of 548) with videos related to

Sort By:
Pageof 55
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 22, 2023
Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trialUdo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 8, 2023
GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromesAlexander Jobs, Jasper Boeddinghaus, Johannes Tobias Neumann, et al.
JACC. Cardiovascular Interventions|September 24, 2025
Percutaneous Coronary Intervention in Multivessel Disease and Infarct-Related Cardiogenic Shock: A DanGer Shock SubstudyJasmine M Marquard, Rasmus P Beske, Christian Hassager, et al.
JACC. Cardiovascular Imaging|February 14, 2021
Impact of Right Ventricular Dysfunction on Outcomes After Transcatheter Edge-to-Edge Repair for Secondary Mitral RegurgitationNicole Karam, Lukas Stolz, Mathias Orban, et al.
ESC Heart Failure|January 29, 2020
Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trialAlexander Jobs, Reinhard Vonthein, Inke R König, et al.
Circulation|October 7, 2009
Absence of thrombospondin-2 causes age-related dilated cardiomyopathyMelissa Swinnen, Davy Vanhoutte, Geert C Van Almen, et al.
Cardio-Oncology (London, England)|July 4, 2025
Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trialLisa B Leypoldt, Linlin Guo, Britta Besemer, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2018
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency departmentPeter A Kavsak, Johannes T Neumann, Louise Cullen, et al.
Atherosclerosis|November 28, 2025
Endothelial CD40L serves as a pro-atherogenic adhesion receptor in the inflamed vasculaturePhilipp Scherrer, Timoteo Marchini, Xiaowei Li, et al.
Pageof 55